LEIPZIG, Germany and ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Switzerland’s ESPAS, a ...
AstraZeneca and Merck & Co have cemented their lead in the PARP inhibitor class with FDA approval for Lynparza in pancreatic cancer, extending the drug’s use into a third type of solid tumour. The US ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...